Avaxim 80 U Pediatric/Avaxim Adult Dosage/Direction for Use

Avaxim 80 U Pediatric: Posology: Primary-vaccination: Primary vaccination is achieved with one vaccine dose of 0.5 mL.
Booster: One booster dose of 0.5 mL is recommended in order to provide long-term protection. This booster will preferably be administered 6 to 36 months following the primary vaccination dose, but administration will be possible until 7 years after this primary vaccination.
Available data on vaccination with AVAXIM 80 U PEDIATRIC show that after the two doses of the initial vaccination schedule, no other booster vaccination is necessary in immunocompetent individuals, which is in agreement with the official recommendations.
It is estimated that anti-HAV antibodies persist several years (beyond 10 years) after the second dose (booster).
Avaxim Adult: Posology: The recommended dose is 0.5 mL for each injection. The primary vaccination is performed with single dose of vaccine followed by a booster injection: 6 to 12 months later for adults over 16 years of age and can be administered up to 36 months after the first vaccination. This vaccine can also be administered as a booster dose of the hepatitis A vaccination in subjects from 16 years of age who received a first injection with the combined typhoid fever (Vi purified polysaccharide) and hepatitis A (inactivated) vaccine between 6 and 36 months earlier.
Method of administration: Avaxim 80 U Pediatric: This vaccine must be administered by the intramuscular route.
The recommended injection site is the deltoid region. The vaccine should not be administered into the buttocks because of the varying amount of fat tissue in this region, that may contribute to variability in effectiveness of the vaccine.
Shake before use until you obtain a homogeneous suspension.
Do not inject by the intravascular route: ensure that the needle does not penetrate a blood vessel. Do not inject by the intradermal route.
Avaxim Adult: It is recommended that this vaccine be administered by the intramuscular route (IM) in order to minimize local reactions.
The recommended injection site is: the deltoid region (upper arm muscle) in adults.
Do not inject via the intravascular route: insure that the needle does not penetrate a blood vessel.
The vaccine should not be administered into the gluteal muscle of the buttocks (due to the presence of varying amounts of adipose tissue) nor intradermally, since these modes of administration may induce a lesser degree of immune response.
In exceptional cases, vaccine may be administered subcutaneously in patients with thrombocytopenia (inadequate amount of platelets, a specific blood component with an important role in blood clotting) or in patients subject to haemorrhages.
This vaccine should not be mixed together with other vaccines in the same syringe.
Do not inject by the intradermal route.